Impact of IQOS Patent Invalidation on Chinese E-Cigarette Industry

Jan.09.2023
Impact of IQOS Patent Invalidation on Chinese E-Cigarette Industry
PMI-BAT patent battle over IQOS temporarily ended, gives Chinese e-cigarette companies more opportunities. Learn from the experience on Jan 12.

In December, the patent war between Philip Morris International (PMI) and British American Tobacco (BAT) temporarily concluded with the invalidation of the IQOS core patent in the UK. In the game between the two tobacco giants in the European market, PMI's four heat-not-burn (HNB) patents were ruled invalid, greatly reducing the risk of HNB products entering the European market and presenting more opportunities for electronic cigarette manufacturers in Europe. So, how does the invalidation of the IQOS core patent affect Chinese electronic cigarette companies? How should Chinese electronic cigarette companies respond to patent issues when going global? What experience can Chinese electronic cigarette companies gain from this patent war?


On January 12th at 2 pm, 2FIRSTS held a seminar on the PMI-HNB Resistance Heater Patent Lawsuit. The event featured keynote speakers from the Beijing Zhong Lun Wende (Kunming) law firm and tobacco industry expert lawyer Tang Shunliang, who provided a comprehensive overview of the patent disputes between two major tobacco companies. They also explored the profound implications for Chinese e-cigarette manufacturers following the breakthrough of the HNB resistance heater patent barrier.


Live broadcast explanation


Title: Seminar on Patent Litigation Case of "PMI-HNB Resistance Heater


Date and Time: January 12th, from 2:00 PM to 3:00 PM.


Speaker: Lawyer Tang Shunliang


Content arrangement:


Key Patent Litigation Analysis for BAT and PMI from 2020 to 2022.


2. Analyzing the Legal Documents to Understand the Battle Strategies between Two Tobacco Giants.


3. In-depth analysis of the core patented technology scheme of the resistance heating element.


What risks and opportunities do export-oriented e-cigarette companies face?


Summarizing the experience in handling foreign patents from PMI patent case.


After the lecture, there will be a dedicated session for discussion and questions, and we encourage active participation and communication.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China Caps E-Cigarette Capacity and Requires Export Compliance Proof to Curb “Involution”
China’s top tobacco regulator has issued a directive aimed at preventing excess capacity and curbing “involution-style” competition in the e-cigarette sector. The notice tightens investment controls, formalizes verified capacity management and requires exporters to submit compliance proof for destination markets, signaling a push toward higher industry concentration and stricter cross-border oversight.
Special Report
Feb.13
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Fiscal benefit, not health, strongest indicator for vape bans – Contributed by Samrat Chowdhery
Data shows 75% of nations with state stakes in tobacco trade ban modern substitutes compared to 10% in the free-market group. What is driving these divergent regulations?
Feb.04
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
U.S. FDA posts TPSAC meeting materials ahead of discussion on ZYN MRTP applications
On January 20, 2026, the U.S. Food and Drug Administration (FDA) posted meeting materials ahead of a virtual Tobacco Products Scientific Advisory Committee (TPSAC) meeting scheduled for January 22, 2026, to discuss modified risk tobacco product (MRTP) applications submitted by Swedish Match USA, Inc. for 20 ZYN nicotine pouch products.
Jan.21 by 2FIRSTS.ai
Product | “Prefilled + Refill” Combo, Up to 30,000 Puffs Claimed: DOJO BLAST 30K PRO Launches in the UK and France
Product | “Prefilled + Refill” Combo, Up to 30,000 Puffs Claimed: DOJO BLAST 30K PRO Launches in the UK and France
DOJO has launched the upgraded BLAST 30K PRO on its official website. The device features a (2+8) ml ×2 “2 ml prefilled pod + 8 ml refill” configuration, delivering 20 ml of e-liquid per kit and claiming up to 30,000 puffs. It is also labeled as fully compatible with BLAST 10K Pods.
Jan.12 by 2FIRSTS.ai
Kazakhstan Investigates Social-Media Vape Sales Linked to a Banking “Drop” Arrangement
Kazakhstan Investigates Social-Media Vape Sales Linked to a Banking “Drop” Arrangement
Kazakhstan’s Financial Monitoring Agency (AFM) in Ulytau Region is conducting a pre-trial investigation into alleged illegal vape sales and the unlawful acquisition of access to a bank account. Authorities say a Satpayev resident has sold banned devices via social media since 2024 and used a “dropper” arrangement to disguise proceeds.
Jan.27 by 2FIRSTS.ai
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10